Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study

Pandey, Sandeep; Baidya, Manabendra; Srivastava, Anurag; Garg, Himanshu

doi:10.4103/njms.njms_509_21

Cited by 5 publications

(9 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TMDs that cause articular pain and mandibular mobility limitation are two main sons for delivering intra-articular injections, except for HD and AB administrations w are performed to treat recurrent subluxation of the temporomandibular [22,24,37,40,44,53,55,57,61,65,66,69,72,73,90,94,96,97,110,111,131,149,160,165,168]. rently, there is an intensive search for the gold standard of TMDs treatment, which i ficult due to the variety of etiologies and the specificity of individual dysfunctions main directions of research on the use of intra-articular injections in this indicatio presented below.…”

Section: Discussionmentioning

confidence: 99%

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Chęciński¹,

Chęcińska

Turosz

et al. 2023

JCM

View full text Add to dashboard Cite

This mapping review aims to identify and discuss current research directions on intracavitary temporomandibular joints (TMJs) injections. The inclusion criteria allowed studies published in the last full six years, based on patients diagnosed with temporomandibular joint disorders (TMDs), treated by TMJ intra-articular injections. Medical databases covered by the Association for Computing Machinery, Bielefeld Academic Search Engine, PubMed, and Elsevier Scopus engines were searched. The results were visualized with tables, charts, and diagrams. Of the 2712 records identified following the selection process, 152 reports were qualified for review. From January 2017, viscosupplementation with hyaluronic acid (HA) was the best-documented injectable administered into TMJ cavities. However, a significant growing trend was observed in the number of primary studies on centrifuged blood preparations administrations that surpassed the previously leading HA from 2021.

show abstract

Section: Discussionmentioning

confidence: 99%

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Chęciński¹,

Chęcińska

Turosz

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…The lack of the articular surfaces' cartilage disruption and leaving the articular disc intact presumably protect against ankylosis [12]. Moreover, in the course of AB therapy, the immobilization of the TMJs is partial and short-term or not implemented at all [7,9,[42][43][44]49,51,52,55,56].…”

Section: Discussionmentioning

confidence: 99%

“…The weakening of muscle strength is achieved by injecting the lateral pterygoid muscle with botulinum neurotoxin [4][5][6]. The elasticity of the ligaments of the joint capsule and the retrodiscal zone is reduced by administering an irritant, which is referred to as prolotherapy [7][8][9]. Limiting the movements of the mandibular head is achieved by soft tissue surgery (joint capsule plication, temporalis muscle scarification, lateral pterygoid muscle plasty), osteoplasty (articular eminence augmentation, zygomatic arch down-fracture), or alloplastic material insertion (screws, mini-plates, etc.)…”

Section: Introduction 1backgroundmentioning

confidence: 99%

“…Compared to them, minimally invasive techniques deserve attention, as they allow for limiting surgical access to a single puncture or a series of punctures. Such protocols consist of intra-and peri-articular injection of hypertonic dextrose or autologous blood (AB) into and around the TMJs cavities [7][8][9]. The latter method of treatment creates conditions within the joint similar to blood extravasation, albeit without injury [12].…”

Section: Introduction 1backgroundmentioning

confidence: 99%

See 1 more Smart Citation

Autologous Blood Injections in Temporomandibular Hypermobility: A Systematic Review

Chęciński,

Chęcińska,

Rąpalska

et al. 2023

JCM

View full text Add to dashboard Cite

The injection of autologous blood (AB) is one of the methods of treatment of recurrent dislocations in the temporomandibular joints (TMJs). Due to the low invasiveness of this technique, it is reasonable to evaluate it in accordance with the standards of evidence-based medicine. The purpose of this systematic review is to identify primary studies on AB injection for the treatment of TMJ hypermobility and assess the therapy for effectiveness. This systematic review was conducted in accordance with the current “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” guidelines. Controlled randomized trials comparing dislocation episode rates, range of motion in the TMJ, or articular pain intensity were adopted as the eligibility criteria. Final searches were conducted on 11 June 2023 using Bielefeld Academic Search Engine, Elsevier Scopus, and the National Library of Medicine: PubMed. Trials were assessed using the “Oxford Center for Evidence-Based Medicine 2011 Levels of Evidence” scale and “A revised Cochrane risk-of-bias tool for randomized trials”. The results of the individual studies were tabulated, syntheses were illustrated in graphs. Twenty two studies involving 982 patients were included in the qualitative analysis, of which seven studies involving 390 patients were subject to quantitative analysis. None of the included randomized controlled trials presented a high risk of bias, 75% of them raised some concerns. In a three-month observation, administration of AB was more efficient in limiting temporomandibular dislocations than hypertonic dextrose (1 study, 32 patients, relative risk = 0.33, odds ratio = 0.29) and no difference in outcomes was observed between intracavitary and pericapsular administration compared to pericapsular injection alone (2 studies, 70 patients, relative risk = 1.00, odds ratio = 1.00). Injections of AB into the temporomandibular joints are effective in preventing further TMJ dislocation episodes in 75–94% of patients. This study received no funding.

show abstract

“…Thus, it appears that further studies using dextrose prolotherapy would be beneficial in determining its efficacy. A more recent study by Pandey et al compared autologous blood and 25% dextrose prolotherapy for the treatment of recurrent TMJ dislocation [ 114 ]. This retrospective study found that autologous blood prolotherapy was more effective in reducing MMO and improving lateral and protrusive mandibular movements, while dextrose prolotherapy was more effective in reducing pain intensity.…”

Section: Technical Advances In Tmj Surgerymentioning

confidence: 99%

Recent Advances in Temporomandibular Joint Surgery

Wroclawski,

Mediratta,

Fillmore

2023

Medicina

View full text Add to dashboard Cite

Temporomandibular disorders (TMDs) affect a high percentage of children and adults worldwide. Surgery may be indicated in severe or recalcitrant cases. Several recent advancements in TMD and temporomandibular joint (TMJ) surgery have elevated understanding and the ability to treat affected patients. We discuss recent advances in TMD epidemiology, juvenile idiopathic arthritis (JIA) of the TMJ, and surgical techniques and technologies. Technical advancements have been identified in TMJ arthroscopy, the treatment of TMJ subluxation and dislocation, and extended prosthetic total TMJ reconstruction (eTMJR). Overall, this review provides valuable insights into significant recent advancements in TMJ disorders and their surgical management.

show abstract

Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study

Cited by 5 publications

References 18 publications

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Autologous Blood Injections in Temporomandibular Hypermobility: A Systematic Review

Recent Advances in Temporomandibular Joint Surgery

Contact Info

Product

Resources

About